Non-invasive vocal biomarker is associated with pulmonary hypertension.

Emerging data suggest that noninvasive voice biomarker analysis is associated with coronary artery disease. We recently showed that a vocal biomarker was associated with hospitalization and heart failure in patients with heart failure. We evaluate the association between a vocal biomarker and invasi...

Full description

Bibliographic Details
Main Authors: Jaskanwal Deep Singh Sara, Elad Maor, Barry Borlaug, Bradley R Lewis, Diana Orbelo, Lliach O Lerman, Amir Lerman
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0231441
id doaj-f845eaaa469744f0b1dccff4673d446a
record_format Article
spelling doaj-f845eaaa469744f0b1dccff4673d446a2021-03-03T21:39:46ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-01154e023144110.1371/journal.pone.0231441Non-invasive vocal biomarker is associated with pulmonary hypertension.Jaskanwal Deep Singh SaraElad MaorBarry BorlaugBradley R LewisDiana OrbeloLliach O LermanAmir LermanEmerging data suggest that noninvasive voice biomarker analysis is associated with coronary artery disease. We recently showed that a vocal biomarker was associated with hospitalization and heart failure in patients with heart failure. We evaluate the association between a vocal biomarker and invasively measured indices of pulmonary hypertension (PH). Patients were referred for an invasive cardiac hemodynamic study between January 2017 and December 2018, and had their voices recorded on three separate occasions to their smartphone prior to each study. A pre-established vocal biomarker was determined based on each individual recording. The intra-class correlation co-efficient between the separate voice recording biomarker values for each individual participant was 0.829 (95% CI 0.740-0.889) implying very good agreement between values. Thus, the mean biomarker was calculated for each patient. Patients were divided into two groups: high pulmonary arterial pressure (PAP) defined as ≥ 35 mmHg (moderate or greater PH), versus lower PAP. Eighty three patients, mean age 61.6 ± 15.1 years, 37 (44.6%) male, were included. Patients with a high mean PAP (≥ 35 mmHg) had on average significantly higher values of the mean voice biomarker compared to those with a lower mean PAP (0.74 ± 0.85 vs. 0.40 ± 0.88 p = 0.046). Multivariate logistic regression showed that an increase in the mean voice biomarker by 1 unit was associated with a high PAP, odds ratio 2.31, 95% CI 1.05-5.07, p = 0.038. This study shows a relationship between a noninvasive vocal biomarker and an invasively derived hemodynamic index related to PH obtained during clinically indicated cardiac catheterization. These results may have important practical clinical implications for telemedicine and remote monitoring of patients with heart failure and PH.https://doi.org/10.1371/journal.pone.0231441
collection DOAJ
language English
format Article
sources DOAJ
author Jaskanwal Deep Singh Sara
Elad Maor
Barry Borlaug
Bradley R Lewis
Diana Orbelo
Lliach O Lerman
Amir Lerman
spellingShingle Jaskanwal Deep Singh Sara
Elad Maor
Barry Borlaug
Bradley R Lewis
Diana Orbelo
Lliach O Lerman
Amir Lerman
Non-invasive vocal biomarker is associated with pulmonary hypertension.
PLoS ONE
author_facet Jaskanwal Deep Singh Sara
Elad Maor
Barry Borlaug
Bradley R Lewis
Diana Orbelo
Lliach O Lerman
Amir Lerman
author_sort Jaskanwal Deep Singh Sara
title Non-invasive vocal biomarker is associated with pulmonary hypertension.
title_short Non-invasive vocal biomarker is associated with pulmonary hypertension.
title_full Non-invasive vocal biomarker is associated with pulmonary hypertension.
title_fullStr Non-invasive vocal biomarker is associated with pulmonary hypertension.
title_full_unstemmed Non-invasive vocal biomarker is associated with pulmonary hypertension.
title_sort non-invasive vocal biomarker is associated with pulmonary hypertension.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2020-01-01
description Emerging data suggest that noninvasive voice biomarker analysis is associated with coronary artery disease. We recently showed that a vocal biomarker was associated with hospitalization and heart failure in patients with heart failure. We evaluate the association between a vocal biomarker and invasively measured indices of pulmonary hypertension (PH). Patients were referred for an invasive cardiac hemodynamic study between January 2017 and December 2018, and had their voices recorded on three separate occasions to their smartphone prior to each study. A pre-established vocal biomarker was determined based on each individual recording. The intra-class correlation co-efficient between the separate voice recording biomarker values for each individual participant was 0.829 (95% CI 0.740-0.889) implying very good agreement between values. Thus, the mean biomarker was calculated for each patient. Patients were divided into two groups: high pulmonary arterial pressure (PAP) defined as ≥ 35 mmHg (moderate or greater PH), versus lower PAP. Eighty three patients, mean age 61.6 ± 15.1 years, 37 (44.6%) male, were included. Patients with a high mean PAP (≥ 35 mmHg) had on average significantly higher values of the mean voice biomarker compared to those with a lower mean PAP (0.74 ± 0.85 vs. 0.40 ± 0.88 p = 0.046). Multivariate logistic regression showed that an increase in the mean voice biomarker by 1 unit was associated with a high PAP, odds ratio 2.31, 95% CI 1.05-5.07, p = 0.038. This study shows a relationship between a noninvasive vocal biomarker and an invasively derived hemodynamic index related to PH obtained during clinically indicated cardiac catheterization. These results may have important practical clinical implications for telemedicine and remote monitoring of patients with heart failure and PH.
url https://doi.org/10.1371/journal.pone.0231441
work_keys_str_mv AT jaskanwaldeepsinghsara noninvasivevocalbiomarkerisassociatedwithpulmonaryhypertension
AT eladmaor noninvasivevocalbiomarkerisassociatedwithpulmonaryhypertension
AT barryborlaug noninvasivevocalbiomarkerisassociatedwithpulmonaryhypertension
AT bradleyrlewis noninvasivevocalbiomarkerisassociatedwithpulmonaryhypertension
AT dianaorbelo noninvasivevocalbiomarkerisassociatedwithpulmonaryhypertension
AT lliacholerman noninvasivevocalbiomarkerisassociatedwithpulmonaryhypertension
AT amirlerman noninvasivevocalbiomarkerisassociatedwithpulmonaryhypertension
_version_ 1714815833656524800